5751 - 5800 of 6422 Results
Title
Year
-
OPENTitle: What the VaP? The meaning of “vascular parkinsonism”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 94Issue #:Start Page: 132End Page: 134Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.12.008Citation Count: 7
-
OPENTitle: Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 27End Page: 32Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.024Citation Count: 17
-
OPENTitle: Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.008Citation Count: 10
-
OPENTitle: Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scoresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 74End Page: 77Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.003Best OA location URL: https://hal.archives-ouvertes.fr/hal-03298502Citation Count: 8
-
OPENTitle: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 25End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.012Best OA location URL: http://www.prd-journal.com/article/S1353802021001450/pdfCitation Count: 19
-
OPENTitle: Plasma NfL, clinical subtypes and motor progression in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 41End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.016Citation Count: 45
-
OPENTitle: Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 79End Page: 85Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.024Best OA location URL: http://www.prd-journal.com/article/S135380202100016X/pdfCitation Count: 66
-
OPENTitle: White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 85Issue #:Start Page: 95End Page: 101Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.031Citation Count: 14
-
OPENTitle: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI databaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 34End Page: 37Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007Best OA location URL: https://repositorio.uca.edu.ar/handle/123456789/11625Citation Count: 12
-
OPENTitle: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 133End Page: 137Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002Best OA location URL: http://www.prd-journal.com/article/S1353802020309007/pdfCitation Count: 5
-
OPENTitle: Special Issue on new therapeutic approaches to Parkinson diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 208Issue #:Start Page: 108998End Page: 108998Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998Citation Count: 5
-
OPENTitle: Preserved motor memory in Parkinson's diseaseJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 167Issue #:Start Page: 108161End Page: 108161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108161Citation Count: 13
-
OPENTitle: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse modelJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 218Issue #:Start Page: 109213End Page: 109213Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109213Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109213Citation Count: 9
-
OPENTitle: Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain StimulationJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 26Issue #: 2Start Page: 364End Page: 373Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.015Citation Count: 4
-
OPENTitle: Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesiclesJournal Name: CytotherapyPublisher: Elsevier BVVol: 23Issue #: 5Start Page: 373End Page: 380Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jcyt.2021.01.001Best OA location URL: http://hdl.handle.net/11380/1251814Citation Count: 182
-
OPENTitle: Are hedge funds' charitable donations strategic?Journal Name: Journal of Corporate FinancePublisher: Elsevier BVVol: 66Issue #:Start Page: 101842End Page: 101842Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jcorpfin.2020.101842Citation Count: 12
-
OPENTitle: Comparison of manual and automated measures of walking speed: Distance and pace matterJournal Name: Experimental GerontologyPublisher: Elsevier BVVol: 170Issue #:Start Page: 111987End Page: 111987Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.exger.2022.111987Best OA location URL: https://doi.org/10.1016/j.exger.2022.111987Citation Count: 3
-
OPENTitle: Effect of glycine transporter 1 inhibition with bitopertin on parkinsonism and L-DOPA induced dyskinesia in the 6-OHDA-lesioned ratJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 929Issue #:Start Page: 175090End Page: 175090Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ejphar.2022.175090Best OA location URL: https://doi.org/10.1016/j.ejphar.2022.175090Citation Count: 10
-
OPENTitle: Persistent depressive symptoms are associated with frontal regional atrophy in patients with Alzheimer's diseaseJournal Name: International Journal of Geriatric PsychiatryPublisher: WileyVol: 38Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/gps.5858Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11217758Citation Count: 8
-
OPENTitle: Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiativeJournal Name: International Journal of Geriatric PsychiatryPublisher: WileyVol: 37Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/gps.5727Citation Count: 8
-
OPENTitle: A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 MutationJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 2Start Page: 508End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.2277Citation Count: 13
-
OPENTitle: A Collaboration for Guiding the Rational Design of Multielement Solid CatalystsJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 62Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/anie.202216327Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.202216327Citation Count: 0
-
OPENTitle: A Collaboration for Guiding the Rational Design of Multielement Solid CatalystsJournal Name: Angewandte ChemiePublisher: WileyVol: 135Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ange.202216327Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202216327Citation Count: 0
-
OPENTitle: Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management StudyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 3Start Page: 844End Page: 856Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12696Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2022-01312%22Citation Count: 12
-
OPENTitle: Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivityJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 3Start Page: 956End Page: 966Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12697Best OA location URL: https://doi.org/10.1002/alz.12697Citation Count: 47
-
OPENTitle: Relationship of serum beta‐synuclein with blood biomarkers and brain atrophyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 4Start Page: 1358End Page: 1371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12790Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12790Citation Count: 36
-
OPENTitle: 146th Annual Meeting American Neurological AssociationJournal Name: Annals of NeurologyPublisher: WileyVol: 90Issue #: S27Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26180Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26180Citation Count: 15
-
OPENTitle: Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tauJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.050391Citation Count: 0
-
OPENTitle: Machine Learning for Predicting Rare Clinical Outcomes—Finding Needles in a HaystackJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 4Issue #: 5Start Page: e2110738End Page: e2110738Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2021.10738Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2780278/wang_2021_ic_210094_1620949822.15523.pdfCitation Count: 17
- Citius, Fortius, Altius—Understanding Which Components Drive Exercise Benefits in Parkinson Disease2021OPENTitle: Citius, Fortius, Altius—Understanding Which Components Drive Exercise Benefits in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 12Start Page: 1443End Page: 1443Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.3744Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2785852/jamaneurology_de_vries_2021_ed_210020_1638811688.29228.pdfCitation Count: 14
-
OPENTitle: Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 12Start Page: 3669End Page: 3675Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03270-6Best OA location URL: https://www.nature.com/articles/s41591-024-03270-6.pdfCitation Count: 18
-
OPENTitle: Single-cell somatic copy number variants in brain using different amplification methods and reference genomesJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s42003-024-06940-wBest OA location URL: https://www.nature.com/articles/s42003-024-06940-w.pdfCitation Count: 2
-
OPENTitle: Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00805-zBest OA location URL: https://www.nature.com/articles/s41531-024-00805-z.pdfCitation Count: 2
-
OPENTitle: Medication recommendation for Parkinson’s disease based on dynamics of symptom progressionJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-024-76941-6Best OA location URL: https://www.nature.com/articles/s41598-024-76941-6.pdfCitation Count: 1
- Vulnerability of Thalamic Nuclei at CSF Interface During the Entire Course of Multiple Sclerosis2024OPENTitle: Vulnerability of Thalamic Nuclei at CSF Interface During the Entire Course of Multiple SclerosisJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1212/nxi.0000000000200222Best OA location URL: https://www.neurology.org/doi/pdfdirect/10.1212/NXI.0000000000200222Citation Count: 4
-
OPENTitle: Biomarker Assessment in Parkinson’s Disease Dementia and Dementia with Lewy Bodies by the Immunomagnetic Reduction Assay and Clinical MeasuresJournal Name: Journal of Alzheimer's Disease ReportsPublisher: SAGE PublicationsVol: 8Issue #: 1Start Page: 1361End Page: 1371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/adr-240110Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease-reports/adr240110?id=journal-of-alzheimers-disease-reports%2Fadr240110Citation Count: 0
-
OPENTitle: Enhancement and evaluation for deep learning-based classification of volumetric neuroimaging with 3D-to-2D knowledge distillationJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-024-80938-6Best OA location URL: https://doi.org/10.1038/s41598-024-80938-6Citation Count: 0
-
OPENTitle: Longitudinal correlation of cerebrospinal fluid GFAP and the progression of cognition decline in different clinical subtypes of Parkinson's diseaseJournal Name: Clinical and Translational SciencePublisher: WileyVol: 17Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/cts.70111Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.70111Citation Count: 0
-
OPENTitle: Relative sparing of dopaminergic terminals in the caudate nucleus is a feature of rest tremor in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00818-8Best OA location URL: https://www.nature.com/articles/s41531-024-00818-8.pdfCitation Count: 6
-
OPENTitle: Circulating blood circular RNA in Parkinson’s Disease; from involvement in pathology to diagnostic tools in at-risk individualsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00839-3Best OA location URL: https://doi.org/10.1038/s41531-024-00839-3Citation Count: 2
- Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbances2024OPENTitle: Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbancesJournal Name: BMC MedicinePublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s12916-024-03766-5Best OA location URL: https://doi.org/10.1186/s12916-024-03766-5Citation Count: 1
-
OPENTitle: Constructing and exploring neuroimaging projects: a survey from clinical practice to scientific researchJournal Name: Insights into ImagingPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 272End Page: 272Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13244-024-01848-9Best OA location URL: https://insightsimaging.springeropen.com/counter/pdf/10.1186/s13244-024-01848-9Citation Count: 1
-
OPENTitle: Dopaminergic PET to SPECT domain adaptation: a cycle GAN translation approachJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 52Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00259-024-06961-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00259-024-06961-x.pdfCitation Count: 4
-
OPENTitle: Comparing machine learning and deep learning models to predict cognition progression in Parkinson's diseaseJournal Name: Clinical and Translational SciencePublisher: WileyVol: 17Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/cts.70066Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.70066Citation Count: 1
-
OPENTitle: The GBA-370Rec Parkinson's disease risk haplotype harbors a potentially pathogenic variant in the mitochondrial gene SLC25A44Journal Name: Molecular Genetics and MetabolismPublisher: Elsevier BVVol: 133Issue #: 1Start Page: 109End Page: 112Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ymgme.2021.03.012Citation Count: 3
-
OPENTitle: Intracellular Thermometry to Study Protein Aggregation Related to Neurodegenerative DiseasesJournal Name: Trends in Biochemical SciencesPublisher: Elsevier BVVol: 46Issue #: 3Start Page: 251End Page: 252Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.tibs.2020.12.003Best OA location URL: http://www.cell.com/article/S096800042030308X/pdfCitation Count: 2
-
OPENTitle: Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imagingJournal Name: Seminars in Arthritis and RheumatismPublisher: Elsevier BVVol: 51Issue #: 5Start Page: 1125End Page: 1133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.semarthrit.2021.08.004Best OA location URL: https://research.vumc.nl/en/publications/d083f460-428b-4cc9-b64c-8e646fc9a1c6Citation Count: 23
-
OPENTitle: An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utilityJournal Name: Seizure: European Journal of EpilepsyPublisher: Elsevier BVVol: 101Issue #:Start Page: 156End Page: 161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.seizure.2022.08.003Best OA location URL: http://www.seizure-journal.com/article/S1059131122001820/pdfCitation Count: 7
-
OPENTitle: Progression of Self-Perceived Speech and Swallowing Impairment in Early Stage Parkinson's Disease: Longitudinal Analysis of the Unified Parkinson's Disease Rating ScaleJournal Name: Journal of Speech, Language, and Hearing ResearchPublisher: American Speech Language Hearing AssociationVol: 65Issue #: 1Start Page: 146End Page: 158Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1044/2021_jslhr-21-00216Best OA location URL: https://doi.org/10.1044/2021_jslhr-21-00216Citation Count: 11
-
OPENTitle: Deep brain stimulation for obsessive–compulsive disorder: a crisis of accessJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 28Issue #: 8Start Page: 1529End Page: 1532Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-022-01879-zCitation Count: 67